Dupilumab efficacy in eosinophilic esophagitis persists for histologic, symptomatic, and endoscopic outcomes regardless of concomitant high-dose proton pump inhibitor use

被引：0
|
作者：
Rothenberg, Marc E. [1 ,2 ]
Schoepfer, Alain [3 ]
Dellon, Evan S. [4 ]
Bredenoord, Albert J. [5 ]
Martire, Erika [6 ]
Sun, Xian [7 ]
Laws, Elizabeth
Mortensen, Eric [7 ]
Maloney, Jennifer [7 ]
Glotfelty, Lila [8 ]
Shabbir, Arsalan [7 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[3] CHU Vaudois, Lausanne, Switzerland
[4] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[5] Acad Med Ctr, Amsterdam, Netherlands
[6] Sanofi, Mississauga, ON, Canada
[7] Regeneron Pharmaceut Inc, Tarrytown, NV USA
[8] Sanofi, Bridgewater, NJ USA
来源：
SWISS MEDICAL WEEKLY | 2024年 / 154卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G4
引用
收藏
页码：29S / 31S
页数：3
相关论文
共 23 条
  • [1] Dupilumab Efficacy in Eosinophilic Esophagitis Persists for Histologic, Symptomatic, and Endoscopic Outcomes Regardless of Concomitant High-Dose Proton Pump Inhibitor Use
    Rothenberg, Marc E.
    Dellon, Evan S.
    Bredenoord, Albert J.
    Sun, Xian
    Laws, Elizabeth
    Mortensen, Eric
    Maloney, Jennifer
    Glotfelty, Lila
    Shabbir, Arsalan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S336 - S337
  • [2] DUPILUMAB EFFICACY IN EOSINOPHILIC ESOPHAGITIS PERSISTS FOR HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC OUTCOMES REGARDLESS OF CONCOMITANT HIGH-DOSE PROTON PUMP INHIBITOR USE
    Pellegatta, G.
    Rothenberg, M. E.
    Dellon, E. S.
    Bredenoord, A. J.
    Sun, X.
    Laws, E.
    Mortensen, E.
    Maloney, J.
    Glotfelty, L.
    Shabbir, A.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S170 - S171
  • [3] Dupilumab improves histologic, symptomatic, and endoscopic outcomes in eosinophilic esophagitis, regardless of history of food allergy or food elimination diets
    Spergel, J.
    Rothenberg, M.
    Cianferoni, A.
    Xia, C.
    Beazley, B.
    Glotfelty, L.
    Shabbir, A.
    ALLERGY, 2023, 78 : 176 - 177
  • [4] DUPILUMAB IMPROVES HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF PRIOR HISTORY OF ESOPHAGEAL DILATION
    Bredenoord, Arjan
    Dellon, Evan S.
    Hirano, Ikuo
    Sun, Xian
    Laws, Elizabeth
    Mortensen, Eric
    Mannent, Leda
    Maloney, Jennifer
    Glotfelty, Lila
    Beazley, Bethany
    Shabbir, Arsalan
    GASTROENTEROLOGY, 2023, 164 (06) : S90 - S91
  • [5] Treatment With High-dose Proton Pump Inhibitors Helps Distinguish Eosinophilic Esophagitis From Noneosinophilic Esophagitis
    Sayej, Wael N.
    Patel, Raza
    Baker, Robert D.
    Tron, Eduardo
    Baker, Susan S.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2009, 49 (04): : 393 - 399
  • [6] IMPROVEMENTS IN HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS ARE MAINTAINED, OR CONTINUE TO IMPROVE, WITH LONG-TERM DUPILUMAB TREATMENT, REGARDLESS OF PRIOR ESOPHAGEAL DILATION
    Bredenoord, Arjan
    Dellon, Evan S.
    Hirano, Ikuo
    Xia, Changming
    Laws, Elizabeth
    Nivens, Michael
    Abdulai, Raolat M.
    Maloney, Jennifer
    Glotfelty, Lila
    Shabbir, Arsalan
    GASTROENTEROLOGY, 2024, 166 (05) : S413 - S413
  • [7] Improvements in histologic, symptomatic, and endoscopic aspects of eosinophilic esophagitis are maintained, or continue to improve, with long-term dupilumab treatment, regardless of prior esophageal dilation
    Bredenoord, Albert J.
    Schlag, Christoph
    Dellon, Evan
    Hirano, Ikuo
    Xia, Changming
    Laws, Elizabeth
    Nivens, Michael
    Abdulai, Raolat
    Maloney, Jennifer
    Glotfelty, Lila
    Shabbir, Arsalan
    SWISS MEDICAL WEEKLY, 2024, 154 : 25S - 26S
  • [8] Improvements In Histologic, Symptomatic, and Endoscopic Aspects of Eosinophilic Esophagitis are Maintained, or Continue to Improve, With Long-Term Dupilumab Treatment Regardless of Prior Esophageal Dilation
    Dellon, Evan S.
    Bredenoord, Arjan
    Hirano, Ikuo
    Xia, Changming
    Laws, Elizabeth
    Abdulai, Raolat M.
    Maloney, Jennifer
    Louisias, Margee
    Radin, Allen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S475 - S476
  • [9] Vonoprazan shows efficacy similar to that of proton pump inhibitors with respect to symptomatic, endoscopic, and histological responses in patients with eosinophilic esophagitis
    Kuzumoto, Takuya
    Tanaka, Fumio
    Sawada, Akinari
    Nadatani, Yuji
    Otani, Koji
    Hosomi, Shuhei
    Kamata, Noriko
    Taira, Koichi
    Nagami, Yasuaki
    Tanigawa, Tetsuya
    Watanabe, Toshio
    Fujiwara, Yasuhiro
    ESOPHAGUS, 2021, 18 (02) : 372 - 379
  • [10] Vonoprazan shows efficacy similar to that of proton pump inhibitors with respect to symptomatic, endoscopic, and histological responses in patients with eosinophilic esophagitis
    Takuya Kuzumoto
    Fumio Tanaka
    Akinari Sawada
    Yuji Nadatani
    Koji Otani
    Shuhei Hosomi
    Noriko Kamata
    Koichi Taira
    Yasuaki Nagami
    Tetsuya Tanigawa
    Toshio Watanabe
    Yasuhiro Fujiwara
    Esophagus, 2021, 18 : 372 - 379
123